Cargando…
Morusin suppresses breast cancer cell growth in vitro and in vivo through C/EBPβ and PPARγ mediated lipoapoptosis
BACKGROUND: Breast cancer is the most fatal malignant cancer among women, the conventional therapeutic modalities of it are limited. Morusin possesses cytotoxicity against some cancer cells in vitro. The purpose of this study is to test the growth inhibition effect of morusin on human breast cancer...
Autores principales: | Li, Haiyan, Wang, Qiaoping, Dong, Lihua, Liu, Chuanlan, Sun, Zhen, Gao, Ling, Wang, Xiujie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634597/ https://www.ncbi.nlm.nih.gov/pubmed/26538209 http://dx.doi.org/10.1186/s13046-015-0252-4 |
Ejemplares similares
-
Morusin shows potent antitumor activity for human hepatocellular carcinoma in vitro and in vivo through apoptosis induction and angiogenesis inhibition
por: Gao, Ling, et al.
Publicado: (2017) -
Mmu-miR-615-3p Regulates Lipoapoptosis by Inhibiting C/EBP Homologous Protein
por: Miyamoto, Yasuhiro, et al.
Publicado: (2014) -
TonEBP suppresses adipogenesis and insulin sensitivity by blocking epigenetic transition of PPARγ2
por: Ho Lee, Jun, et al.
Publicado: (2015) -
Protein arginine methyltransferase PRMT1 promotes adipogenesis by modulating transcription factors C/EBPβ and PPARγ
por: Zhu, Qi, et al.
Publicado: (2022) -
Mechanism of morusin on breast cancer via network pharmacology and in vitro experiments
por: Li, Hangzhen, et al.
Publicado: (2023)